Being a lifelong musician can help protect certain tracts of the brain’s white matter from damage during aging, potentially warding…
Articles by Marisa Wexler, MS
Multiple Sclerosis News Today brought you daily coverage of the latest scientific research, advances in treatment, and clinical trials related…
MS-STAT2, a clinical trial testing whether the cholesterol-lowering medication simvastatin might slow disability progression in secondary progressive multiple…
Certain treatments for multiple sclerosis (MS) — specifically, anti-CD20 antibody therapies and Gilenya (fingolimod) — are likely to…
There is minimal evidence that the expensive anti-inflammatory medication Acthar Gel (repository corticotropin injection) is more effective than inexpensive…
Leaders of the International Progressive MS Alliance have proposed a global research strategy to find better ways to care for…
Children and young adults who spend more time outdoors in the sunshine are less likely to develop multiple sclerosis…
An imaging technique called optical coherence tomography (OCT) could be useful for monitoring nervous system damage in people with…
The National MS Society has announced it is funding 13 new research projects that seek to better understand the…
Tecfidera (dimethyl fumarate) and Aubagio (teriflunomide) are the preferred disease-modifying treatments for managing relapsing-remitting multiple sclerosis (RRMS) in…
While older multiple sclerosis (MS) patients whose conditions are stable commonly stop using disease-modifying therapies (DMTs), a study…
A class of immune-suppressing medications called TNF-alpha inhibitors can reduce the efficacy of vaccines for COVID-19, according to a study…
Certain cell therapies that hold promise for treating autoimmune diseases like multiple sclerosis might work not because of the…
Immunic Therapeutics has enrolled the first participant in its Phase 3 ENSURE clinical trial program, which is testing the company’s…
Cholesterol made by neurons is crucial for repairing long-term damage to the myelin sheath, the fatty coating around nerve fibers…
The oral medication Vumerity (diroximel fumarate) has been approved by the European Commission to treat adults with relapsing-remitting…
Measuring levels of the protein serum neurofilament light chain (NfL)Â can help to identify people with relapsing-remitting multiple sclerosis (RRMS)…
The multiple sclerosis (MS) treatment Tecfidera (dimethyl fumarate) triggers immune cell death by interacting with a protein called…
Ocrevus (ocrelizumab) continues to be the most commonly prescribed therapy for progressive forms of multiple sclerosis (MS), including…
Among people with nervous system damage indicative of multiple sclerosis (MS), but who don’t yet have the disease —…
Not drinking alcohol significantly increases the risk of developing multiple sclerosis (MS), especially if a person also is a…
This year’s Women Against Multiple Sclerosis (WAMS) Gala, which aims to raise funds for multiple sclerosis (MS) research, will…
People who contract infectious mononucleosis — colloquially known as “mono” — during childhood or adolescence are at a roughly two…
Colder ambient temperatures may ease the inflammation that drives multiple sclerosis (MS), early research in a mouse model suggests.
Black and Hispanic/Latinx people with multiple sclerosis (MS) in the U.S. tend to have more severe disease, but less…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…